Genovate Biotechnology Co., Ltd. (TPEX:4130)
Taiwan · Delayed Price · Currency is TWD 32.50
-0.10 (-0.31%)
Apr 17, 2026, 1:30 PM CST
Genovate Biotechnology Market Cap
Genovate Biotechnology has a market cap or net worth of 3.7 billion as of April 17, 2026. Its market cap has increased by 40.77% in one year.
Market Cap
3.70B
Enterprise Value
3.22B
Revenue
492.41M
Ranking
n/a
PE Ratio
316.46
Stock Price
32.50
Market Cap Chart
Since November 3, 2008, Genovate Biotechnology's market cap has increased from 664.80M to 3.70B, an increase of 456.09%. That is a compound annual growth rate of 10.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 3.70B | 17.33% |
| Dec 31, 2025 | 3.15B | 35.56% |
| Dec 31, 2024 | 2.32B | -20.11% |
| Dec 29, 2023 | 2.91B | -17.02% |
| Dec 30, 2022 | 3.51B | 31.05% |
| Dec 30, 2021 | 2.68B | -15.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Pharmaceuticals | 4.60B |
| Medigen Biotechnology | 4.25B |
| Sagittarius Life Science | 4.19B |
| ACRO Biomedical | 4.09B |
| Energenesis Biomedical CO.,LTD. | 4.06B |
| BioGend Therapeutics | 3.82B |
| Shine-On BioMedical | 3.29B |
| SYN-TECH Chem. & Pharm. | 3.22B |